Future Table of Contents

Future Table of Contents

Volume 26, Number 6 (December 2019)

Based on the author provided metadata and may not accurately reflect the final Table of Contents

Countercurrents: The Bias of Choice
S. A. Narod

Breast Cancer Screening Policy– Good Science Should Trump Bad Politics
M. J. Yaffe

Evaluation of an Interlaboratory Proficiency Testing Scheme for Tumor Next-generation Sequencing in Ontario
T. L. Stockley

The SOmatic Curation and Interpretation Across Laboratories (SOCIAL) Project – Current State of Solid Tumor Variant Interpretation for Molecular Pathology in Canada
T. L. Stockley

Combined cancer patient reported symptom and health utility tool for routine clinical implementation: A real world comparison of ESAS and EQ5D across multiple cancer sites
M. Moskovitz, J. Kevin, J. Su, H. Naik, C. Brown, L. Eng, T. Wang, Hiten Naik, J. Kuo, Yvonne Leung, Wei Xu, N. Mittmann, L. Moody, L. Barbera, G. Devins, M. Li, D. Howell, G. Liu

Implementation of a Comprehensive Smoking Cessation Program in Cancer Care
N. Abdelmutti, J. Brual, J. Papadakos, S. Fathima, J. Jones, D. Goldstein, L. Eng, T. Papadakos, G. Liu, M. E. Giuliani

The Physician’s Achilles Heel – Surviving an Adverse Event
I. Stukalin, B. C. Lethebe, W. Temple

A Retrospective Observational Study to Estimate the Attrition of Patients Across Lines of Systemic Treatment for Metastatic Colorectal Cancer in Canada
H. Kennecke, S. Berry, J. Maroun, P. Kavan, N. Aucoin, F. Couture, B. Gillesby

Patient-physician discordance in goals of care for patients with advanced cancer
S. L. Douglas, B. J. Daly, N. J. Meropol, A. R. Lipson

Preferences of Canadian Patients and Physicians for Adjuvant Treatments for Melanoma
D. Stellato, M. Thabane, C. Eichten, T. E. Delea

Recurrence and mortality following breast conserving surgery without radiation
K. Guidolin

Radiotherapy Versus Surgery Alone in the Treatment of Retroperitoneal Sarcoma: A Population-Based Comparison
B. Turner, L. Hampton, L. Mack, D. Schiller, C. Robertson-More, H. Li, M. Quan, A. Bouchard-Fortier

Impact of gut microbiome on immune checkpoint inhibitors efficacity. A systematic review.
J. Pierrard

A Primer on the Genetics of Medullary Thyroid Cancer
V. Larouche, A. Akirov, C. M. Thomas, M. K. Krzyzanowska, S. Ezzat

Report from the 20th Annual Western Canadian Gastrointestinal Cancer Consensus Conference. Saskatoon, Saskatchewan; September 28–29th, 2018
D. Le

African-Caribbean Cancer Consortium (AC3) Scientific and Training Conference 2017 Meeting Report
C. Ragin, B. F. Morrison-Blidgen

Statistical significance of bevacizumab trials when considering the portfolio of all studies.
V. Prasad

Re: Countercurrents: Is now the right time to pull the plug on mammography?
A. J. Coldman, G. Doyle, J. Payne

Upcoming in Current Oncology

Can less be more? Organ preservation strategies in the management of rectal cancer.
C. Brown

Current and emerging biomarkers in metastatic colorectal cancer
J. Loree

Metastatic Colorectal Cancer: Therapeutic Options for Treatment Refractory Disease
A. Parmar, K. KW. Chan, Y. Ko

Optimizing Biologic sequencing in mCRC – First line and beyond
J. M. Hubbard

Adjuvant Therapy for Stage II and III Colon Cancer - Risk Stratification, Treatment Duration and Future Directions
U. Bender, Y. S. Rho, I. Barrera, S. Aghajanyan, J. Acoba, P. Kavan

Role of Real-World Evidence in Informing Cancer Care: Lessons from Colorectal Cancer
W. Y. Cheung